Re: Aluminum Adjuvant in Vaccines Causes Risk to Children According to New Journal Report

[Guest guest]

No $hi†, Sherlock! ~ Maureen R. Gradvohl ~ From: Sheri Nakken <vaccinedangers@...> Sent: Sunday, January 29, 2012 5:45 PM Subject: Aluminum Adjuvant in Vaccines Causes Risk to Children According to New Journal Report

Aluminum Adjuvant in Vaccines Causes Risk to Children According to New

Journal Report

A new Canadian study of the mechanisms of aluminum adjuvant toxicity in

pediatric patients confirms that immune challenges during early

development, including those vaccine-induced, can lead to permanent

detrimental alterations of the brain and immune system function. Lucija

Tomljenovic, PhD and A. Shaw, PhD of the University of

British Columbia’s evidence-based study was recently published in

Lupus, the only fully peer reviewed international journal devoted

exclusively to lupus (and related autoimmune disease) research.

<http://www.prweb.com/releases/2012/1/prweb9146755.htm>

New York, NY (PRWEB) January 29, 2012

A new Canadian study of the mechanisms of aluminum adjuvant toxicity in

pediatric patients confirms that immune challenges during early

development, including those vaccine-induced, can lead to permanent

detrimental alterations of the brain and immune system function. Lucija

Tomljenovic, PhD and A. Shaw, PhD of the University of

British Columbia’s evidence-based study was recently published in

Lupus, the only fully peer reviewed international journal devoted

exclusively to lupus (and related disease) research.

Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in

pediatric populations.

Lupus. 2011;21(2):223-230

Summary

Immune challenges during early development, including those

vaccine-induced, can lead to permanent detrimental alterations of the

brain and immune system function. Experimental evidence also shows that

simultaneous administration of as little as two to three immune adjuvants

can overcome genetic resistance to autoimmunity. In some developed

countries, by the time children are 4 to 6 years old, they will have

received a total of 126 antigenic compounds along with high amounts of

aluminum (Al) adjuvants through routine vaccinations. According to the US

Food and Drug Administration, safety assessments for vaccines have often

not included appropriate toxicity studies because vaccines have not been

viewed as inherently toxic.

Taken together, these observations raise plausible concerns about the

overall safety of current childhood vaccination programs.

When assessing adjuvant toxicity in children, several key points ought to

be considered:

1) During prenatal and early postnatal development the

brain is extremely vulnerable to neurotoxic insults;

2) Aluminum is a neurotoxin and a strong immune

stimulant. Hence, aluminum has all the necessary biochemical properties

to induce neuro-immune diseases. Autism is one such disease. Namely,

autism is characterized by dysfunctional immunity and abnormalities in

brain function;

3) In adult humans aluminum vaccine adjuvants have been

linked to a variety of serious autoimmune and inflammatory conditions,

yet children are regularly exposed to much higher amounts of aluminium

from vaccines than adults;

4) It is often incorrectly assumed that peripheral

immune challenges (analogous to vaccinations) do not affect brain

function. However, it is now clearly established that there is a

cross-talk between the nervous and the immune system. It is also

demonstrated that this cross-talk plays a crucial role in both

immunoregulation as well as brain function. In turn, perturbations of the

neuro-immune regulatory system have been demonstrated in many autoimmune

diseases and are thought to be driven by a hyperactive immune

response;

5) The same components of the neuro-immune regulatory

system that have key roles in both brain development and immune function

are heavily affected by aluminum adjuvants;

In summary, research evidence shows that increasing concerns about

current vaccination practices may indeed be warranted. Because children

may be most at risk of vaccine-induced complications, a rigorous

evaluation of the vaccine-related adverse health impacts in the pediatric

population is urgently needed.

Study abstract here

<http://www.ncbi.nlm.nih.gov/pubmed/22235057>

very good presentation of the study here- fulltext of the study is not

available to the public

<

http://gaia-health.com/gaia-blog/2012-01-14/mechanisms-of-aluminimum-adjuvant-revealed-vaccine-risks-to-children-clarified/

>

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start January 27 & Feb 2

[Guest guest]

These aluminium adjuvants are used as placebos in the HPV vaccine trials. ~ Maureen R. Gradvohl ~ From: Sheri Nakken <vaccinedangers@...> Sent: Sunday, January 29, 2012 5:45 PM Subject: Aluminum Adjuvant in Vaccines Causes Risk to Children According to New Journal Report

Aluminum Adjuvant in Vaccines Causes Risk to Children According to New

Journal Report

A new Canadian study of the mechanisms of aluminum adjuvant toxicity in

pediatric patients confirms that immune challenges during early

development, including those vaccine-induced, can lead to permanent

detrimental alterations of the brain and immune system function. Lucija

Tomljenovic, PhD and A. Shaw, PhD of the University of

British Columbia’s evidence-based study was recently published in

Lupus, the only fully peer reviewed international journal devoted

exclusively to lupus (and related autoimmune disease) research.

<http://www.prweb.com/releases/2012/1/prweb9146755.htm>

New York, NY (PRWEB) January 29, 2012

A new Canadian study of the mechanisms of aluminum adjuvant toxicity in

pediatric patients confirms that immune challenges during early

development, including those vaccine-induced, can lead to permanent

detrimental alterations of the brain and immune system function. Lucija

Tomljenovic, PhD and A. Shaw, PhD of the University of

British Columbia’s evidence-based study was recently published in

Lupus, the only fully peer reviewed international journal devoted

exclusively to lupus (and related disease) research.

Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in

pediatric populations.

Lupus. 2011;21(2):223-230

Summary

Immune challenges during early development, including those

vaccine-induced, can lead to permanent detrimental alterations of the

brain and immune system function. Experimental evidence also shows that

simultaneous administration of as little as two to three immune adjuvants

can overcome genetic resistance to autoimmunity. In some developed

countries, by the time children are 4 to 6 years old, they will have

received a total of 126 antigenic compounds along with high amounts of

aluminum (Al) adjuvants through routine vaccinations. According to the US

Food and Drug Administration, safety assessments for vaccines have often

not included appropriate toxicity studies because vaccines have not been

viewed as inherently toxic.

Taken together, these observations raise plausible concerns about the

overall safety of current childhood vaccination programs.

When assessing adjuvant toxicity in children, several key points ought to

be considered:

1) During prenatal and early postnatal development the

brain is extremely vulnerable to neurotoxic insults;

2) Aluminum is a neurotoxin and a strong immune

stimulant. Hence, aluminum has all the necessary biochemical properties

to induce neuro-immune diseases. Autism is one such disease. Namely,

autism is characterized by dysfunctional immunity and abnormalities in

brain function;

3) In adult humans aluminum vaccine adjuvants have been

linked to a variety of serious autoimmune and inflammatory conditions,

yet children are regularly exposed to much higher amounts of aluminium

from vaccines than adults;

4) It is often incorrectly assumed that peripheral

immune challenges (analogous to vaccinations) do not affect brain

function. However, it is now clearly established that there is a

cross-talk between the nervous and the immune system. It is also

demonstrated that this cross-talk plays a crucial role in both

immunoregulation as well as brain function. In turn, perturbations of the

neuro-immune regulatory system have been demonstrated in many autoimmune

diseases and are thought to be driven by a hyperactive immune

response;

5) The same components of the neuro-immune regulatory

system that have key roles in both brain development and immune function

are heavily affected by aluminum adjuvants;

In summary, research evidence shows that increasing concerns about

current vaccination practices may indeed be warranted. Because children

may be most at risk of vaccine-induced complications, a rigorous

evaluation of the vaccine-related adverse health impacts in the pediatric

population is urgently needed.

Study abstract here

<http://www.ncbi.nlm.nih.gov/pubmed/22235057>

very good presentation of the study here- fulltext of the study is not

available to the public

<

http://gaia-health.com/gaia-blog/2012-01-14/mechanisms-of-aluminimum-adjuvant-revealed-vaccine-risks-to-children-clarified/

>

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start January 27 & Feb 2